Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 85.40
+0.50 (0.59%)
Oct 8, 2026, 1:30 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 12.65 billion as of October 9, 2026. It is the 16,523rd most valuable company in the world and the 643rd biggest in Taiwan. Its market cap has decreased by 33.02% in one year.
Market Cap
12.65B
Enterprise Value
10.50B
Revenue
10.12B
Global Rank
Country Rank
#643 Taiwan
PE Ratio
11.10
ChartMarket Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 12.65B, an increase of 444.70%. That is a compound annual growth rate of 5.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 12.65B | -32.49% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 24.60B |
| Handa Pharmaceuticals | 20.32B |
| TTY Biopharm Company | 19.97B |
| Synmosa Biopharma | 15.80B |
| YungShin Global Holding | 15.29B |
| ScinoPharm Taiwan | 14.98B |
| Foresee Pharmaceuticals | 12.45B |
| Standard Chemical & Pharmaceutical | 10.02B |